New York City Focusing On Antiviral Pills for ‘Non-White’ Individuals

New york city state’s Department of Health (DOH) announced recently that non-white people need to be focused on over white individuals for anti-viral tablets in short supply.

The DOH statement, dated December 27, stated restricted supply of oral antivirals will “require suppliers to prioritize treatment for patients at greatest threat for serious COVID-19 till more product appears.”

Under a list of eligibility requirements for oral antiviral treatment, it stated one requirement ought to be “have a medical condition or other aspects that increase their danger for serious health problem” which one risk aspect is being a “non-white race or Hispanic/Latino ethnic culture must be considered a danger aspect, as longstanding systemic health and social injustices have actually added to an increased threat of extreme illness and death from COVID-19.”

The announcement likewise connected to a different undated DOH fileon prioritization which contained the same assistance.

Columnist Karol Markowicz accentuated the standards in a tweet, where she said, “NY State Department of Health warns they don’t have enough Paxlovid or Monoclonal Antibody Treatment and white people require not apply.”

Reporter and author Abigail Shrier called for a constitutional challenge to the guidance. “If the state can discriminate racially for medical treatment, then the 14th Change genuinely has no meaning. There needs to be a constitutional challenge to this right away,” she tweeted.

Former Trump administration adviser Stephen Miller placed blame on the signal sent by the Biden Administration. He tweeted:

Political analyst Dave Rubin tweeted: “Systemic bigotry, brought to you by progressive Democrats …”

Follow Breitbart News’s Kristina Wong on Twitteror on Facebook.

About the author

Click here to add a comment

Leave a comment: